Giancarlo Comi Selected Research

Methylprednisolone

1/2023	Sars-CoV2 infection in pregnant women with multiple sclerosis.
7/2022	A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis.
1/2021	Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giancarlo Comi Research Topics

Disease

170	Multiple Sclerosis 01/2024 - 04/2003
47	Relapsing-Remitting Multiple Sclerosis 09/2023 - 03/2006
16	COVID-19 01/2024 - 01/2020
16	Disease Progression 01/2024 - 06/2003
14	Atrophy 01/2024 - 06/2005
14	Inflammation (Inflammations) 12/2022 - 12/2002
13	Demyelinating Diseases (Demyelinating Disease) 01/2024 - 06/2003
13	Stroke (Strokes) 01/2023 - 08/2008
12	Infections 01/2024 - 02/2010
12	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 02/2003
10	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 05/2004
9	Optic Neuritis (Retrobulbar Neuritis) 01/2024 - 04/2016
7	Neoplasms (Cancer) 07/2023 - 01/2013
7	Ischemic Stroke 01/2023 - 01/2009
7	Progressive Multifocal Leukoencephalopathy 02/2022 - 01/2014
7	Neuroinflammatory Diseases 01/2021 - 03/2009
6	Parkinson Disease (Parkinson's Disease) 01/2020 - 03/2013
6	Cognitive Dysfunction 01/2020 - 11/2010
6	Dementia (Dementias) 01/2019 - 01/2016
6	Migraine Disorders (Migraine) 10/2016 - 05/2008
5	Chronic Progressive Multiple Sclerosis 01/2022 - 09/2004
5	Fatigue 12/2018 - 11/2002
5	Headache (Headaches) 04/2016 - 05/2008
5	Epilepsy (Aura) 02/2016 - 11/2012
4	Lymphopenia (Lymphocytopenia) 01/2020 - 02/2010
4	Pain (Aches) 12/2018 - 09/2013
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018 - 10/2009
4	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 03/2017 - 04/2012
3	Ganglion Cysts (Ganglion) 01/2024 - 01/2017
3	Macular Edema 06/2021 - 02/2010
3	Spontaneous Abortion (Miscarriage) 01/2020 - 10/2012
3	Atrioventricular Block 11/2019 - 02/2010
3	Herpes Zoster 04/2019 - 02/2010
3	Polyneuropathies (Polyneuropathy) 01/2019 - 12/2007
3	Brain Diseases (Brain Disorder) 01/2019 - 10/2008
3	Frontotemporal Dementia (Semantic Dementia) 01/2017 - 01/2012
3	Primary Progressive Aphasia 01/2015 - 01/2012
3	Pathologic Processes 08/2014 - 12/2011
2	Nervous System Diseases (Neurological Disorders) 11/2022 - 07/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 02/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021 - 12/2017
2	Opportunistic Infections (Opportunistic Infection) 11/2019 - 04/2019
2	Immune Reconstitution Inflammatory Syndrome 01/2019 - 01/2014
2	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2019 - 10/2009

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 12/2021 - 06/2005
23	Fingolimod Hydrochloride (FTY720)FDA Link 09/2023 - 09/2006
21	Natalizumab (Tysabri)FDA Link 11/2022 - 10/2009
20	InterferonsIBA 01/2023 - 06/2003
18	Interferon-betaIBA 01/2023 - 05/2005
18	Cladribine FDA LinkGeneric 12/2022 - 02/2010
17	teriflunomideIBA 07/2023 - 10/2011
17	Glatiramer Acetate (Copaxone)FDA Link 11/2022 - 11/2002
15	TabletsIBA 12/2022 - 02/2010
14	Interferon beta-1a FDA Link 01/2024 - 10/2004
10	ozanimodIBA 01/2024 - 04/2016
9	ocrelizumabIBA 11/2022 - 01/2017
8	Alemtuzumab (Campath)FDA Link 01/2023 - 01/2020
7	Retinaldehyde (Retinal)IBA 01/2024 - 05/2016
7	laquinimodIBA 04/2022 - 01/2012
7	AntibodiesIBA 01/2022 - 07/2003
6	GadoliniumIBA 12/2021 - 11/2012
6	Oligoclonal BandsIBA 12/2021 - 01/2004
5	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022 - 05/2004
5	Messenger RNA (mRNA)IBA 10/2021 - 05/2004
5	Interferon beta-1b (Betaseron)FDA Link 12/2017 - 10/2009
5	Proteins (Proteins, Gene)FDA Link 05/2017 - 01/2004
4	Rituximab (Mabthera)FDA Link 11/2022 - 05/2017
4	Sphingosine-1-Phosphate ReceptorsIBA 06/2021 - 04/2016
4	nabiximols (Sativex)IBA 01/2019 - 11/2015
4	Immunologic Factors (Immunomodulators)IBA 01/2018 - 09/2014
4	frovatriptan (Allegro)FDA Link 01/2017 - 08/2014
4	Amyloid (Amyloid Fibrils)IBA 01/2017 - 02/2003
4	Alanine Transaminase (SGPT)IBA 01/2017 - 03/2014
4	Mitoxantrone (Novantrone)FDA LinkGeneric 05/2013 - 09/2008
3	Dimethyl FumarateIBA 01/2023 - 11/2021
3	Methylprednisolone FDA LinkGeneric 01/2023 - 01/2021
3	salicylhydroxamic acid (SHAM)IBA 11/2022 - 11/2013
3	siponimodIBA 11/2021 - 01/2020
3	IronIBA 11/2015 - 01/2010
3	Intravenous Immunoglobulins (IVIG)FDA Link 12/2010 - 11/2003
3	Protons (Proton)IBA 10/2009 - 06/2003
2	Monoclonal AntibodiesIBA 07/2023 - 01/2020
2	Complement System Proteins (Complement)IBA 12/2022 - 09/2013
2	VaccinesIBA 04/2022 - 01/2020
2	nitazoxanide (NTZ)FDA Link 02/2022 - 03/2015
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 10/2015
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 08/2013
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 01/2019
2	CannabinoidsIBA 01/2019 - 11/2012

Therapy/Procedure

69	Therapeutics 01/2024 - 02/2003
9	Transcranial Magnetic Stimulation 07/2021 - 05/2013
7	Transplantation 01/2023 - 08/2009
5	Wearable Electronic Devices 12/2023 - 07/2019
4	Injections 07/2020 - 07/2013
3	Neurological Rehabilitation 02/2022 - 01/2016
3	Treatment Delay 01/2022 - 06/2009
3	Hematopoietic Stem Cell Transplantation 01/2021 - 03/2014
3	Stem Cell Transplantation 11/2017 - 06/2005
2	Immunomodulation 01/2023 - 01/2021
2	Transcranial Direct Current Stimulation 11/2022 - 11/2013